Related content

Designing Studies to Find Early Signals of Efficacy

By Brown Michael J.  

Journal of Biopharmaceutical Statistics, Vol. 22, Iss. 6, 2012-11 ,pp. : 1097-1108

Taylor & Francis Ltd

Access to resources Recommend Favorite

Practical Aspects of Designing and Conducting Pharmacoeconomic Studies in Japan

By Doherty J.   Sato K.  

PharmacoEconomics, Vol. 21, Iss. 13, 2003-01 ,pp. : 913-925

Adis International

Access to resources Recommend Favorite

Abrasive Blasting Agents: Designing Studies to Evaluate Relative Risk

By Hubbs Ann   Greskevitch Mark   Kuempel Eileen   Suarez Fernando   Toraason Mark  

Journal of Toxicology and Environmental Health, Vol. 68, Iss. 11-12, 2005-06 ,pp. : 999-1016

Taylor & Francis Ltd

Access to resources Recommend Favorite

Physiogenomic analysis links serum creatine kinase activities during statin therapy to vascular smooth muscle homeostasis

By Ruaño Gualberto   Thompson Paul D   Windemuth Andreas   Smith Andrew   Kocherla Mohan   Holford Theodore R   Seip Richard   Wu Alan HB  

Pharmacogenomics, Vol. 6, Iss. 8, 2005-12 ,pp. : 865-872

Future Medicine

Access to resources Recommend Favorite

Pharmacokinetic and Pharmacodynamic Data to be Derived from Early-Phase Drug Development: Designing Informative Human Pharmacology Studies

By Cohen Adam  

Clinical Pharmacokinetics, Vol. 47, Iss. 6, 2008-01 ,pp. : 373-381

Adis International

Access to resources Recommend Favorite